FR-229934
FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction[1].
Product Specifications
CAS Number
[799841-02-4]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/fr-229934.html
Purity
98.65
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C(Cl)=C3)C2=C1)NS(=O)(CCCCC)=O
Molecular Formula
C21H23Cl2N3O3S
Molecular Weight
468.40
References & Citations
[1]PANDYA J, et, al. Liquid oral formulations for pde v inhibitors. WO2019130052A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
